InvestorsHub Logo
Followers 839
Posts 120405
Boards Moderated 18
Alias Born 09/05/2002

Re: smarterer post# 7600

Thursday, 05/30/2013 4:54:05 PM

Thursday, May 30, 2013 4:54:05 PM

Post# of 428880

If I was BP, if be worried about Teva or Elan buying or partnering here. A drug that complements and/or replaces any of the statins ought to scare the crap out of them…

Your comment applies only to AZN insofar as Crestor is the only consequential statin drug that’s still on-patent. Since AZN has decided to go in a different direction, there are zero pharma companies with a patented statin drug who could be interested in AMRN.

A buyout by a non-statin company such as ELN is another story; that might actually come to fruition, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News